The Planarian Model in Pharmacology, Toxicology, and Neuroscience
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 131
Special Issue Editor
Special Issue Information
Dear Colleagues,
The main biological claim to fame of freshwater planarians and related flatworms is the fact that some species display an uncanny capacity for regeneration, including the complete (and correct) regeneration of their relatively complex nervous system. Planarians have been used to test a variety of chemical compounds since at least the 18th century. However, arguably the systematic study of the pharmacology of planarians began in the 1970s with the studies of Drs. G. Palladini, A. Carolei, G. Venturini, and their colleagues at the University of Rome, Italy, in the context of the dopaminergic and cholinergic systems and eventually, on the effects of the abused drug, cocaine, in this organism. Since then, the planarian pharmacology field has blossomed, alongside the use of planarians in scientific fields like toxicology and neurobiology, establishing planarians as mainstream animal models beyond regenerative and developmental biology. In this Special Issue, we are pleased to present a sample of cutting-edge research showcasing the application of the planarian model in pharmacology, toxicology, and neuroscience.
Prof. Dr. Oné R. Pagán
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- planarians
- pharmacology
- toxicology
- neuroscience
- neurotransmission
- regeneration
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
